These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 19366756

  • 1. Clopidogrel in acute coronary syndromes.
    Chua D, Ignaszewski A.
    BMJ; 2009 Apr 14; 338():b1180. PubMed ID: 19366756
    [No Abstract] [Full Text] [Related]

  • 2. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct 14; 18(103):193-5. PubMed ID: 19877380
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
    Antman EM, Wiviott SD, Murphy SA, Voitk J, Hasin Y, Widimsky P, Chandna H, Macias W, McCabe CH, Braunwald E.
    J Am Coll Cardiol; 2008 May 27; 51(21):2028-33. PubMed ID: 18498956
    [Abstract] [Full Text] [Related]

  • 6. The safety of clopidogrel.
    Mangalpally KK, Kleiman NS.
    Expert Opin Drug Saf; 2011 Jan 27; 10(1):85-95. PubMed ID: 21091040
    [Abstract] [Full Text] [Related]

  • 7. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
    MMW Fortschr Med; 2008 Oct 16; 150(42):52-3. PubMed ID: 18983063
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome.
    Walker CW, Dawley CA, Fletcher SF.
    Am Fam Physician; 2007 Dec 01; 76(11):1643-5. PubMed ID: 18092705
    [No Abstract] [Full Text] [Related]

  • 12. [The ARCTIC study].
    Cattaneo M, Ottani F.
    G Ital Cardiol (Rome); 2013 Sep 01; 14(9):559-63. PubMed ID: 23903274
    [No Abstract] [Full Text] [Related]

  • 13. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
    Marcucci R.
    G Ital Cardiol (Rome); 2010 Jun 01; 11(6):481-7; discussion 487. PubMed ID: 20922874
    [No Abstract] [Full Text] [Related]

  • 14. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
    Simmons BB, Salzman BE.
    J Fam Pract; 2008 Jan 01; 57(1):26-32. PubMed ID: 18171566
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome.
    Persson J, Lindbäck J, Hofman-Bang C, Lagerqvist B, Stenestrand U, Samnegard A.
    EuroIntervention; 2011 Apr 01; 6(9):1046-52, 8-9. PubMed ID: 21518675
    [Abstract] [Full Text] [Related]

  • 17. Dosing of clopidogrel and aspirin in acute coronary syndromes.
    Merella P, Casu G, Meloni I.
    N Engl J Med; 2010 Dec 16; 363(25):2466-7; author reply 2467-8. PubMed ID: 21158665
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality.
    Banerjee S, Varghese C, Samuel J, Weideman RA, Little BB, Kelly KC, Rao SV, Reilly RF, Brilakis ES.
    Am J Cardiol; 2008 Nov 01; 102(9):1159-62. PubMed ID: 18940284
    [Abstract] [Full Text] [Related]

  • 19. Potential Interaction between clopidogrel and proton pump inhibitors.
    Howard PA, Vacek JL.
    Am J Cardiovasc Drugs; 2009 Nov 01; 9(6):353-9. PubMed ID: 19929033
    [Abstract] [Full Text] [Related]

  • 20. Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial.
    Collet JP, Montalescot G, Steg PG, Steinhubl SR, Fox KA, Hu TF, Johnston SC, Hamm CW, Bhatt DL, Topol EJ.
    Arch Cardiovasc Dis; 2009 Nov 01; 102(6-7):485-96. PubMed ID: 19664568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.